Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Radiation Oncology Physician in Tampa, FL
NPI: 1053707521Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get M.D. Daniel's Phone Numberphone_androidMobile
Get M.D. Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2020 - 2026
American Board of Radiology
Radiation Oncology
University of South Florida Morsani/Moffitt Cancer Center
Residency • Radiation Oncology
2016 - 2020
Emory School of Medicine
med.emory.edu
Internship • Transitional Year
2015 - 2016
Medical School
Until 2015
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77014Ct scan guidance for insertion of radiation therapy fields | 228 | 483 |
| 2 | 77334Design and construction of complex radiation treatment device | 70 | 278 |
| 3 | 77263Complex radiation therapy planning | 66 | 73 |
| 4 | 77300Calculation of radiation therapy dose | 55 | 306 |
| 5 | G6002Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 46 | 76 |
The Lung Graded Prognostic Assessment: Continued Evolution of Brain Metastases Prognostication.
Authors: Kamran Ahmed, Hsiang-Hsuan Yu
Journal: Int J Radiat Oncol Biol Phys
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.
Authors: Nikhil Khushalani, Tobin Strom, Jane Messina, Akash Parekh, Arash Naghavi, Vernon Sondak, Jimmy Caudell, Louis Harrison, Javier Torres-Roca, Amod Sarnaik, Jonathan Zager
Journal: J Natl Compr Canc Netw
Patterns of Failure in Patients With Recurrent High-Grade Glioma Treated With Hypofractionated Stereotactic Re-Irradiation, Pembrolizumab, and Bevacizumab.
Authors: R. Padmanabhan, G.G. Zhang, Daniel E. Oliver, J. Graham, D. Grass, Solmaz Sahebjam, Hsiang-Hsuan Michael Yu
Publication Date: 2021-11
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: RADIATION: Hypofractionated Stereotactic Radiosurgery
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Endocrine therapy, RADIATION: Stereotactic Radiosurgery (SRS)